Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04141 (
granulocyte-macrophage colony-stimulating factor
)
6,790
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
M-TAT is a cytokine-dependent cell line with the potential to differentiate along the erythroid and megakaryocytic lineages. We cultured M-TAT cells long term (> 1 year) in the continuous presence of erythropoietin (EPO),
granulocyte-macrophage colony-stimulating factor
(
GM-CSF
), or stem cell factor (SCF). These long term cultures are referred to as M-TAT/EPO, M-TAT/
GM-CSF
, and M-TAT/SCF cells, respectively. Hemoglobin concentration and gamma-globin and
erythroid delta-aminolevulinate synthase
mRNA levels were significantly higher in M-TAT/EPO cells than in M-TAT/
GM-CSF
cells. When the supplemented cytokine was switched from
GM-CSF
to EPO, hemoglobin synthesis in M-TAT/
GM-CSF
cells increased rapidly (within 5 h), and the level of GATA-1 mRNA increased. In contrast, the addition of
GM-CSF
to the M-TAT/EPO cell culture decreased the amount of hemoglobin, even in the presence of EPO, indicating that the EPO signal for erythroid differentiation is suppressed by
GM-CSF
. Thus, erythroid development of M-TAT cells is promoted by EPO and suppressed by
GM-CSF
. These results support the hypothesis that EPO actively influences the programming of gene expression required for erythroid progenitor cell differentiation.
...
PMID:Erythropoietin-dependent induction of hemoglobin synthesis in a cytokine-dependent cell line M-TAT. 796 90